Please wait a minute...
European Journal of Gynaecological Oncology  2020, Vol. 41 Issue (4): 638-639    DOI: 10.31083/j.ejgo.2020.04.5007
Case Report Previous articles | Next articles
Clear cell carcinoma of the vagina followed by breast cancer in a patient without prenatal diethylstilbestrol exposure
Isao Otsuka1, *()
1Department of Obstetrics and Gynecology, Kameda Medical Center, 929 Higashi-cho, Kamogawa, Japan
Download:  PDF(691KB)  ( 254 ) Full text   ( 6 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Clear cell carcinoma of the vagina or cervix and breast cancer are the only malignancies associated with prenatal diethylstilbestrol (DES) exposure. Clear cell carcinoma of the vagina develops mainly in young women, and rarely develops in elderly women without DES exposure. A 68-year-old woman, who had not experienced prenatal DES exposure or received hormone replacement therapy, presented with vaginal bleeding. Pelvic examination revealed a 3-cm polypoid solid mass in the posterior fornix. Biopsy showed clear cell carcinoma. She underwent radical hysterectomy with posterior vaginal wall resection. Thirty-four months after the surgery, she developed pulmonary metastasis and underwent video-assisted tumor resection. Forty-nine months after the initial surgery, screening mammography revealed an abnormal breast mass. Biopsy revealed invasive lobular carcinoma, and she underwent breast resection followed by radiation therapy. She remained well with no evidence of disease 89 months after the initial surgery.
Key words:  Clear cell carcinoma      Vagina      Pulmonary metastasis      Breast cancer     
Submitted:  05 October 2018      Accepted:  03 December 2018      Published:  15 August 2020     
*Corresponding Author(s):  ISAO OTSUKA     E-mail:  otsuka.isao@kameda.jp

Cite this article: 

Isao Otsuka. Clear cell carcinoma of the vagina followed by breast cancer in a patient without prenatal diethylstilbestrol exposure. European Journal of Gynaecological Oncology, 2020, 41(4): 638-639.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2020.04.5007     OR     https://ejgo.imrpress.com/EN/Y2020/V41/I4/638

[1] Hayal Uzelli Şimşek, Turgay Şimşek, Deniz Şahin, Sertaç Ata Güler, Nuh Zafer Cantürk, Nihat Zafer Utkan. Evaluation of the effect of surgical timing on systemic response to trauma in premenopausal patients by using cytokine levels[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 577-582.
[2] Hiroshi Yoshida, Megumi Yamamoto, Hiroyuki Shigeta. Successful treatment of uterine cervical carcinoma with extensive vaginal lesions using laparoscopic surgery: A case report[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 629-633.
[3] Terumi Tanigawa, Maki Matoda, Yoichi Aoki, Hidetaka Nomura, Sanshiro Okamoto, Kohei Omatsu, Hiroyuki Kanao, Nobuhiro Takeshima. A case of recurrent smooth muscle tumor of uncertain malignant potential with abdominal dissemination after morcellation[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 648-650.
[4] Luca Roncati, Maria Vadalà, Pepe Valentina, Veronica Corazzari, Beniamino Palmieri. Genomic profiling in gynaecological oncology: the future is now![J]. European Journal of Gynaecological Oncology, 2020, 41(3): 323-325.
[5] Guolin Liu, Rui Zhang. Postmenopausal recurrent retrovaginal extramural gastrointestinal stromal tumor: a case report[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 473-475.
[6] I. Ferreira, C. Estevinho, A. Torgal, C. Carrapatoso, F. Costa. Should we search for high-risk HPV in vaginal vault Pap smear after hysterectomy due to CIN2+?[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 157-162.
[7] Mingming Sun, Tong Gao, Yuqing Zhao, Weiguo Hu, Wei Jiang. Primary fallopian tube carcinoma clinically manifested as vaginal adenocarcinoma in a post-hysterectomy patient: a case report and literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 312-316.
[8] D. Korfias, J. Contis, M. Frangou-Plemenou, K. Gennatas, A. Kondis, D. Vlachodimitropoulos. Stem cells in ductal breast cancer: immunohistochemical expression of CD44, CD24, CD133, and ALDH-1 markers in 104 cases[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 36-41.
[9] A. Conversano, C. Balleyguier, M.K. De Fremicourt, H. Alkhashnam, C. Mazouni, J. Arfi-Rouche, N. Leymarie, F. Rimareix. Magnetic seed localisation for non-palpable lesions in patients undergoing breast conservative surgery[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 48-53.
[10] M. Sakaguchi, T. Maebayashi, T. Aizawa, N. Ishibashi, T. Saito. High-dose-rate intracavitary brachytherapy for non-palpable and non-visible recurrent vaginal stump tumors after hysterectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 54-59.
[11] S.Wang, W.J. Chen, Z.M. Song, Q. Li, X. Shen, Y.D. Wu, L. Zhu, Q.X. Ma, D.M. Xing. Long non-coding RNA ROR accelerates the progression of breast cancer via promoting stemness in MCF-10A cells[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 106-109.
[12] Y.H. Wang, J.M. Gong, Q. Tian, G. Shi, J.Y. Ruan. The endoscopic therapy of infant vaginal embryonal rhabdomyosarcoma: a case report[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 151-152.
[13] M. Englert-Golon, B. Burchardt, R. Słopień, N. Smolarek, S. Sajdak. Ovarian and endometrial cancer after breast cancer - three primary malignancies in a single patient[J]. European Journal of Gynaecological Oncology, 2020, 41(1): 153-154.
[14] P.-S. Huang, C.-T. Yue, W.-Y. Kao, J.-M. Hwang, H.-W. Kuo, S.-C. Huang. Undifferentiated endometrial sarcoma of the cervix: a case report[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1035-1038.
[15] S. Kim, K. J. Min, S. Lee, J. H. Hong, J. K. Lee, N. W. Lee, J. Y. Song. Clear cell carcinoma arising from abdominal wall endometriosis with lymph node metastasis – a rare case report and review of the literature[J]. European Journal of Gynaecological Oncology, 2019, 40(6): 1047-1050.
No Suggested Reading articles found!